Pulmonary adverse events with leflunomide - Myth or reality? [10]

Rheumatology

Volumn 46, Issue 2, 2007, Pages 372-

  Balakrishnan, C ^a   Dasgupta, B ^a  

^a SOUTHEND UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEFLUNOMIDE;

ANKYLOSING SPONDYLITIS; CLINICAL PROTOCOL; DISEASE DURATION; DRUG MONITORING; DRUG WITHDRAWAL; HUMAN; HYALINE MEMBRANE DISEASE; INTERSTITIAL LUNG DISEASE; LETTER; LUNG DISEASE; LUNG EMBOLISM; LUNG TOXICITY; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; ISOXAZOLES; LUNG DISEASES; MALE; MIDDLE AGED;

EID: 33846665401     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel373     Document Type: Letter

References (6)

1. Saravanan V, Kelly C. Drug-related pulmonary problems in patients with rheumatoid arthritis. Rheumatology 2006;45:787-9.
2. Balakrishnan C, Fernando M, Kalke S, Rae AM, Dasgupta B. Serious pulmonary complications in patients treated with leflunomide. Rheumatology 2001;40(Suppi. 1):83-4.
3. Ito S, Sumida T. Interstitial lung disease associated with leflunomide. Intern Med 2004;43:1103-4.
4. Kamata Y, Nara H, Mamimura et al. Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction. Intern Med 2004;43:1201-4.
5. McCurry J. Japan deaths spark concerns over arthritis drug. Lancet 2004;363:461.
6. Takeshi M, Akiyama Y, Akiba H, Adachi D, Hirano M, Mimura T. Leflunomide induced acute interstitial pneumonia. J Rheumatol 2005;32:1160-3.